Literature DB >> 33464017

Toxic Shock Syndrome in Patients Younger than 21 Years of Age, United States, 2006-2018.

Jessica Leung1, Joseph Y Abrams2, Ryan A Maddox2, Shana Godfred-Cato3, Lawrence B Schonberger2, Ermias D Belay2.   

Abstract

We examined the incidence of toxic shock syndrome in the United States during 2006-2018 among persons <21 years old with commercial or Medicaid-insurance using administrative data. There were 1008 commercially-insured and 481 Medicaid-insured toxic shock syndrome cases. The annual rate was 1 per 100,000 and stable over time. Rates were even lower in children <5 years old and stable over time.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh：

Year:  2021        PMID： 33464017      PMCID： PMC8842798          DOI： 10.1097/INF.0000000000003011

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   3.806


  10 in total

1.  Epidemiology of Invasive Group A Streptococcal Infections in the United States, 2005-2012.

Authors:  George E Nelson; Tracy Pondo; Karrie-Ann Toews; Monica M Farley; Mary Lou Lindegren; Ruth Lynfield; Deborah Aragon; Shelley M Zansky; James P Watt; Paul R Cieslak; Kathy Angeles; Lee H Harrison; Susan Petit; Bernard Beall; Chris A Van Beneden
Journal:  Clin Infect Dis       Date:  2016-04-22       Impact factor: 9.079

Review 2.  Toxic shock syndrome in children: epidemiology, pathogenesis, and management.

Authors:  Yu-Yu Chuang; Yhu-Chering Huang; Tzou-Yien Lin
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

3.  Toxic shock syndrome surveillance in UK children.

Authors:  S Adalat; T Dawson; S J Hackett; J E Clark
Journal:  Arch Dis Child       Date:  2014-05-01       Impact factor: 3.791

4.  Toxic shock syndrome in the United States: surveillance update, 1979 1996.

Authors:  R A Hajjeh; A Reingold; A Weil; K Shutt; A Schuchat; B A Perkins
Journal:  Emerg Infect Dis       Date:  1999 Nov-Dec       Impact factor: 6.883

5.  Prevalence, comorbidities and mortality of toxic shock syndrome in children and adults in the USA.

Authors:  Mark A Strom; Derek Y Hsu; Jonathan I Silverberg
Journal:  Microbiol Immunol       Date:  2017-11       Impact factor: 1.955

6.  Epidemiology and Clinical Relevance of Toxic Shock Syndrome in US Children.

Authors:  James T Gaensbauer; Meghan Birkholz; Michael A Smit; Roger Garcia; James K Todd
Journal:  Pediatr Infect Dis J       Date:  2018-12       Impact factor: 2.129

7.  Toxic shock syndrome in Australian children.

Authors:  Katherine Y H Chen; Michael Cheung; David P Burgner; Nigel Curtis
Journal:  Arch Dis Child       Date:  2016-04-26       Impact factor: 3.791

8.  Staphylococcal toxic shock syndrome 2000-2006: epidemiology, clinical features, and molecular characteristics.

Authors:  Aaron S DeVries; Lindsey Lesher; Patrick M Schlievert; Tyson Rogers; Lourdes G Villaume; Richard Danila; Ruth Lynfield
Journal:  PLoS One       Date:  2011-08-10       Impact factor: 3.240

9.  Manifestations of Toxic Shock Syndrome in Children, Columbus, Ohio, USA, 2010-20171.

Authors:  Aliza Cook; Sarah Janse; Joshua R Watson; Guliz Erdem
Journal:  Emerg Infect Dis       Date:  2020-06       Impact factor: 6.883

10.  Infectious shock and toxic shock syndrome diagnoses in hospitals, Colorado, USA.

Authors:  Michael A Smit; Ann-Christine Nyquist; James K Todd
Journal:  Emerg Infect Dis       Date:  2013-11       Impact factor: 6.883
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.